Ligand Pharmaceuticals Inc (NASDAQ:LGND)

66.39
Delayed Data
As of 10:28am ET
 -0.06 / -0.09%
Today’s Change
41.99
Today|||52-Week Range
80.21
+24.77%
Year-to-Date

Today’s Trading

Previous close66.45
Today’s open66.00
Day’s range65.40 - 67.49
Volume64,300
Average volume (3 months)289,627
Market cap$1.3B
Dividend yield--
Data as of 10:28am ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+41.94%
Earnings growth (next 5 years)+38.40%
Revenue growth (last year)+31.78%
P/E ratio118.6
Price/Sales16.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...-0.95-2.06%
MACKMerrimack Pharmaceut...+0.21+1.79%
USNAUSANA Health Science...-1.25-1.24%
ACHNAchillion Pharmaceut...-0.50-4.12%
Data as of 10:44am ET, 03/04/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President, Chief Operating Officer &
Director
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account